- Home
- TRS vs SYRE Comparison
TRS vs SYRE Comparison
Compare TRS & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRS
- SYRE
- Stock Information
- Founded
- TRS 1986
- SYRE 2013
- Country
- TRS United States
- SYRE United States
- Employees
- TRS N/A
- SYRE N/A
- Industry
- TRS Industrial Specialties
- SYRE Biotechnology: Pharmaceutical Preparations
- Sector
- TRS Industrials
- SYRE Health Care
- Exchange
- TRS Nasdaq
- SYRE Nasdaq
- Market Cap
- TRS 1.0B
- SYRE 841.4M
- IPO Year
- TRS 2007
- SYRE 2016
- Fundamental
- Price
- TRS $25.68
- SYRE $16.62
- Analyst Decision
- TRS Strong Buy
- SYRE Buy
- Analyst Count
- TRS 1
- SYRE 6
- Target Price
- TRS $40.00
- SYRE $55.00
- AVG Volume (30 Days)
- TRS 357.0K
- SYRE 475.8K
- Earning Date
- TRS 07-29-2025
- SYRE 05-08-2025
- Dividend Yield
- TRS 0.62%
- SYRE N/A
- EPS Growth
- TRS N/A
- SYRE N/A
- EPS
- TRS 0.77
- SYRE N/A
- Revenue
- TRS $939,580,000.00
- SYRE N/A
- Revenue This Year
- TRS $6.37
- SYRE N/A
- Revenue Next Year
- TRS $3.56
- SYRE N/A
- P/E Ratio
- TRS $33.42
- SYRE N/A
- Revenue Growth
- TRS 3.80
- SYRE N/A
- 52 Week Low
- TRS $19.33
- SYRE $10.91
- 52 Week High
- TRS $28.51
- SYRE $40.26
- Technical
- Relative Strength Index (RSI)
- TRS 55.93
- SYRE 63.17
- Support Level
- TRS $25.59
- SYRE $14.75
- Resistance Level
- TRS $26.50
- SYRE $17.11
- Average True Range (ATR)
- TRS 0.68
- SYRE 0.79
- MACD
- TRS -0.10
- SYRE 0.21
- Stochastic Oscillator
- TRS 55.02
- SYRE 81.99
About TRS TriMas Corporation
TriMas Corp designs, develops and manufactures a diverse set of products primarily for the consumer products, aerospace & defense, and industrial markets . The company operates through three segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The aerospace segment supplies blind bolts, fasteners, rivets, and other products for the aerospace industry. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners.
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.